TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored November 18, 1994